These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 2469115

  • 1. Effect of a low-molecular weight serine proteinase inhibitor (camostate) on amylase release from isolated pancreatic acini.
    Göke B, Leferink J, Göke R, Adler G.
    Res Exp Med (Berl); 1989; 189(1):33-8. PubMed ID: 2469115
    [Abstract] [Full Text] [Related]

  • 2. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
    Otsuki M, Fujii M, Nakamura T, Tani S, Okabayashi Y.
    Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829
    [Abstract] [Full Text] [Related]

  • 3. Intracellular mechanism responsible for reduced enzyme secretion from camostate-induced hypertrophied pancreas.
    Herzig KH, May D, Louie DS, Takahashi T, Göke B, Owyang C.
    Digestion; 1990 Oct; 46 Suppl 2():195-201. PubMed ID: 1702070
    [Abstract] [Full Text] [Related]

  • 4. Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats.
    Otsuki M, Tani S, Okabayashi Y, Fuji M, Nakamura T, Fujisawa T, Itoh H.
    Dig Dis Sci; 1990 Feb; 35(2):242-50. PubMed ID: 1689237
    [Abstract] [Full Text] [Related]

  • 5. Pancreatic growth: interaction of exogenous cholecystokinin, a protease inhibitor, and a cholecystokinin receptor antagonist in mice.
    Niederau C, Liddle RA, Williams JA, Grendell JH.
    Gut; 1987 Feb; 28 Suppl(Suppl):63-9. PubMed ID: 2446964
    [Abstract] [Full Text] [Related]

  • 6. Effect of camostate administration for two weeks on experimental pancreatitis in mice and rats.
    Leonhardt U, Seidensticker F, Stöckmann F, Creutzfeldt W.
    Pancreas; 1993 Jan; 8(1):98-102. PubMed ID: 7678329
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Modulation by CR-1409 (lorglumide), a cholecystokinin receptor antagonist, of trypsin inhibitor-enhanced growth of azaserine-induced putative preneoplastic lesions in rat pancreas.
    Douglas BR, Woutersen RA, Jansen JB, de Jong AJ, Rovati LC, Lamers CB.
    Cancer Res; 1989 May 01; 49(9):2438-41. PubMed ID: 2706631
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effect of synthetic protease inhibitor camostate on pancreatic exocrine function in rats.
    Otsuki M, Ohki A, Okabayashi Y, Suehiro I, Baba S.
    Pancreas; 1987 May 01; 2(2):164-9. PubMed ID: 3628222
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of long-term CCK stimulation and CCK blockade on pancreatic and intestinal growth, morphology, and function.
    Niederau C, Lüthen R, Niederau M, Strohmeyer G, Ferrell LD, Grendell JH.
    Digestion; 1990 May 01; 46 Suppl 2():217-25. PubMed ID: 2262055
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Stimulation of pancreatic secretory process in the rat by low-molecular weight proteinase inhibitor. I. Dose-response study on enzyme content and secretion, cholecystokinin release and pancreatic fine structure.
    Rausch U, Adler G, Weidenbach H, Weidenbach F, Rudolff D, Koop I, Kern HF.
    Cell Tissue Res; 1987 Jan 01; 247(1):187-93. PubMed ID: 2435411
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.